Teleflex to separate into two companies by mid-2026 and acquire Biotronik's Vascular Intervention unit for €760 million. CFO ...
In conjunction with its Q4 2024 results, MedTech firm Teleflex (NYSE:TFX) announced plans to separate the company’s Urology, ...
Medical technology company Teleflex (NYSE:TFX) will be reporting earnings tomorrow before market open. Here’s what to look ...
Teleflex (NYSE: TFX) announced today that it plans to separate its Urology, Acute Care and OEM businesses into a new publicly ...
Good morning, ladies and gentlemen, and welcome to the Teleflex Fourth Quarter 2024 Earnings Conference Call. At this time all participants have been placed in a listen-only mode. At the end of the ...
Acquisition will further advance Teleflex’s Interventional portfolio with a differentiated global suite of coronary vascular ...
The upcoming report from Teleflex (TFX) is expected to reveal quarterly earnings of $3.86 per share, indicating an increase of 14.2% compared to the year-ago period. Analysts forecast revenues of ...
Truist lowered the firm’s price target on Teleflex (TFX) to $149 from $200 and keeps a Hold rating on the shares. The firm says the company’s ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results